Staurosporine induces platelet apoptosis through p38 mitogen-activated protein kinase signaling pathway

Clinical Laboratory

Volumn 61, Issue 7, 2015, Pages 717-726

  Zhao, Lili ^a   Lu, Guoyuan ^a   Zhao, Qing ^a   Zhang, Mingyi ^a   Chen, Mengxing ^a   Zhang, Jiansheng ^a   Dai, Kesheng ^a  

^a THE FIRST AFFILIATED HOSPITAL OF SOOCHOW UNIVERSITY   (China)

Author keywords

Apoptosis; Platelets; Staurosporine

Indexed keywords

CASPASE 8; CASPASE 9; CYTOCHROME C; MITOGEN ACTIVATED PROTEIN KINASE P38; PHOSPHATIDYLSERINE; PROTEIN BAK; PROTEIN BAX; STAUROSPORINE; ANTINEOPLASTIC AGENT; APOPTOSIS REGULATORY PROTEIN; PROTEIN KINASE INHIBITOR;

APOPTOSIS; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MEMBRANE DEPOLARIZATION; MITOCHONDRIAL MEMBRANE POTENTIAL; SIGNAL TRANSDUCTION; THROMBOCYTE; UPREGULATION; WESTERN BLOTTING; ANTAGONISTS AND INHIBITORS; DOSE RESPONSE; DRUG EFFECTS; ENZYMOLOGY; METABOLISM; MITOCHONDRIAL MEMBRANE; PATHOLOGY; PHOSPHORYLATION;

ANTINEOPLASTIC AGENTS; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; BLOOD PLATELETS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME ACTIVATION; HUMANS; MEMBRANE POTENTIAL, MITOCHONDRIAL; MITOCHONDRIAL MEMBRANES; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; PROTEIN KINASE INHIBITORS; SIGNAL TRANSDUCTION; STAUROSPORINE;

EID: 84938698270     PISSN: 14336510     EISSN: None     Source Type: Journal    
DOI: 10.7754/Clin.Lab.2014.141103     Document Type: Article

References (49)

1. Lin KH, Chang HC, Lu WJ, et al. Comparison of the relative activities of inducing platelet apoptosis stimulated by various plate- let-activating agents. Platelets 2009;20:575-81.
2. Leytin V, Allen DJ, Mykhaylov S, et al. Pathologic high shear stress induces apoptosis events in human platelets. Biochem Bioph Res Co 2004;320:303-10.
3. Leytin V, Freedman J. Platelet apoptosis in stored platelet concentrates and other models. Transfus Apher Sci 2003;28:285-95.
4. Newland AC. Is interleukin 3 active in anticancer drug-induced thrombocytopenia? Cancer Chemoth Pharm 1996;38:83-8.
5. Cassidy CA, Peterson P, Cirera L, Roychowdhury DF. Incidence of thrombocytopenia with gemcitabine-based therapy and influence of dosing and schedule. Anti-Cancer Drug 2001;12:383-5.
6. Jardim D, Rodrigues C, Novis Y, Rocha V, Hoff P. Oxaliplatin- related thrombocytopenia. Ann Oncol 2012;23:1937-42.
7. Yang SW, Cordell GA. Metabolism studies of indole derivatives using a staurosporine producer, Streptomyces staurosporeus. J Nat Prod 1997;60:44-8.
8. Wang Y, Yang H, Liu H, Huang J, Song X. Effect of staurosporine on the mobility and invasiveness of lung adenocarcinoma A549 cells: An in vitro study. BMC Cancer 2009;9:174.
9. Schultheiss M, Schnichels S, Miteva K, et al. Staurosporine-in- duced differentiation of the RGC-5 cell line leads to apoptosis and cell death at the lowest differentiating concentration. Graefes Arch Clin Exp Ophthalmol 2012;250:1221-9.
10. Zhang BF, Peng FF, Zhang JZ, Wu DC. Staurosporine induces apoptosis in NG108-15 cells. Acta Pharmacol Sin 2003;24:663-9.
11. Prehn J, Jordan J, Ghadge G, et al. Ca2+ and reactive oxygen species in staurosporine-induced neuronal apoptosis. J Neurochem 1997;68:1679- 85.
12. Thuret G, Chiquet C, HerTag S, et al. Mechanisms of staurosporine induced apoptosis in a human corneal endothelial cell line. Brit J Ophthalmol 2003;87:346-52.
13. Cai M, Chen Q, Chen C, et al. Activation of Triggering Receptor Expressed on Myeloid Cells-1 Protects Monocyte from Apoptosis through Regulation of Myeloid Cell Leukemia-1. Anesthesiology 2013;118:1140-9.
14. Zhang XD, Gillespie SK, Hersey P. Staurosporine induces apoptosis of melanoma by both caspase-dependent and -independent apoptotic pathways. Mol Cancer Ther 2004;3:187.
15. White MJ, Schoenwaelder SM, Josefsson EC, et al. Caspase-9 mediates the apoptotic death of megakaryocytes and platelets, but is dispensable for their generation and function. Blood 2012;119: 4283-90.
16. Sordet O, Khan QA, Plo I, et al. Apoptotic topoisomerase I-DNA complexes induced by staurosporine-mediated oxygen radicals. J Biol Chem 2004;279:50499-504.
17. Kim BJ, Ryu SW, Song BJ. JNK- And p38 kinase-mediated phosphorylation of Bax leads to its activation and mitochondrial translocation and to apoptosis of human hepatoma HepG2 cells. J Biol Chem 2006;281:21256-65.
18. Antonsson A, Persson JL. Induction of apoptosis by staurosporine involves the inhibition of expression of the major cell cycle proteins at the G(2)/m checkpoint accompanied by alterations in Erk and Akt kinase activities. Anticancer Res 2009;29:2893-988.
19. Feng G, Kaplowitz N. Mechanism of staurosporine-induced apoptosis in murine hepatocytes. Am J Physiol Gastrointest Liver Physiol 2002;282:G825-34.
20. Manns J, Daubrawa M, Driessen S, et al. Triggering of a novel intrinsic apoptosis pathway by the kinase inhibitor staurosporine: Activation of caspase-9 in the absence of Apaf-1. FASEB J 2011; 25:3250-61.
21. Bernard B, Fest T, Pretet J, Mougin C. Staurosporine-induced apoptosis of HPV positive and negative human cervical cancer cells from different points in the cell cycle. Cell Death Differ 2001;8:, 234 .
22. Patel V, Lahusen T, Leethanakul C, et al. Antitumor activity of UCN-01 in carcinomas of the head and neck is associated with altered expression of cyclin D3 and p27KIPl. Clin Cancer Res 2002;8:3549-60.
23. Nakano T, Hanasaki K, Arita H. Role of protein kinase C in U46619-induced platelet shape change, aggregation and secretion. Thromb Res 1989;56:299-306.
24. Wu CC, Ko FN, Huang TF, Teng CM. Mechanisms-regulated platelet spreading after initial platelet contact with collagen. Biochem Biophys Res Commun 1996;220:388-93.
25. Kocher M, Clemetson KJ. Staurosporine both activates and inhibits serine/threonine kinases in human platelets. Biochem J 1991; 275:301-6.
26. Gupta Y, Mallika V, Srivastava DK. Interaction of LDL and platelets in ischemic and ischemic risk subjects. Indian J Clin Biochem 2005;20:87-94.
27. Vayssiere JL, Petit PX, Risler Y, Mignotte B. Commitment to apoptosis is associated with changes in mitochondrial biogenesis and activity in cell lines conditionally immortalized with simian virus 40. Proc Natl Acad Sci U S A 1994;91:11752-6.
28. Castedo M, Macho A, Zamzami N, et al. Mitochondrial perturbations define lymphocytes undergoing apoptotic depletion in vivo. Eur J Immunol 1995;25:3277-84.
29. Li Q, Sato EF, Zhu X, Inoue M. A simultaneous release of SOD 1 with cytochrome c regulates mitochondria-dependent apoptosis. Mol Cell Biochem 2009;322:151-9.
30. Wang Z, Li S, Shi Q, Yan R, Liu G, Dai K. Calmodulin antagonists induce platelet apoptosis. Thromb Res 2010;125:340-50.
31. Wang ZC, Shi QW, Li SP, Du J, Liu J, Dai KS. Hyperthermia induces platelet apoptosis and glycoprotein lb alpha ectodomain shedding. Platelets 2010;21:229-37.
32. Li S, Wang Z, Liao Y, et al. The glycoprotein lb alpha-von Wille- brand factor interaction induces platelet apoptosis. J Thromb Hemost 2010;8:341-50.
33. Leytin V, Allen DJ, Mutlu A, Gyulkhandanyan AV, Mykhaylov S, Freedman J. Mitochondrial control of platelet apoptosis: Effect of cyclosporin A, an inhibitor of the mitochondrial permeability transition pore. Lab Invest 2009;89:374-84.
34. Mason KD, Carpinelli MR, Fletcher JI, et al. Programmed anu- clear cell death delimits platelet life span. Cell 2007;128:1173-86.
35. Cassidy-Stone A, Chipuk JE, Ingerman E, et al. Chemical inhibition of the mitochondrial division dynamin reveals its role in Bax/Bak- dependent mitochondrial outer membrane permeabilization. Dev Cell 2008;14:193-204.
36. Tait SW, Green DR. Mitochondria and cell death: outer membrane permeabilization and beyond. Nat Rev Mol Cell Bio 2010; 11:621-32.
37. Leytin V. Apoptosis in the anucleate platelet. Blood Rev 2012;26: 51-63.
38. Jiang X, Wang X. Cytochrome c promotes caspase-9 activation by inducing nucleotide binding to Apaf-1. J Biol Chem 2000;275: 31199-203.
39. Viswanath V, Wu Y, Boonplueang R, et al. Caspase-9 activation results in downstream caspase-8 activation and bid cleavage in 1- methyl-4- phenyl-l, 2, 3, 6-tetrahydropyridine-induced Parkinson's disease. J Neurosci 2001;21:9519-28.
40. van Engeland M, Nieland LJW, Ramaekers FCS, Schutte B, Reutelingsperger CPM. Annexin V-affinity assay: A review on an apoptosis detecti on system based on phosphatidylserine exposure. Cytometry 1998;31:1-9.
41. Martin SJ, Reutelingsperger C, McGahon AJ, et al. Early redistribution of plasma membrane phosphatidylserine is a general feature of apopto sis regardless of the initiating stimulus: Inhibition by over expression of Bcl-2 and Abl. J Exp Med 1995;182: 1545-56.
42. Schoenwaelder SM, Yuan YP, Josefsson EC, et al. Two distinct pathways regulate platelet phosphatidylserine exposure and pro- coagulant function. Blood 2009;114:663-6.
43. Wada T, Penninger JM. Mitogen-activated protein kinases in apoptosis regulation. Oncogene 2004;23:2838-49.
44. Van derWal DE, Gitz E, Du VX, et al. Arachidonic acid depletion extends survival of cold-stored platelets by interfering with the [glycoprotein Iba-14-3-3] association. Hematologica 2012;97: 1514-22.
45. Gyulkhandanyan AV, Mutlu A, Freedman J, Leytin V. Markers of platelet apoptosis: methodology and applications. J Thromb Thrombolysis 2012;33:397-411.
46. Kuida K, Zheng TS, Na S, et al. Decreased apoptosis in the brain and premature lethality in CPP32-deficient mice. Nature 1996; 384:368-72.
47. Alvarez S, Blanco A, Fresno M, Mufioz-Fernandez MA. TNF-a contributes to caspase-3 independent apoptosis in neuroblastoma cells: Role ofNFAT. PLoS One 2011;6:e16100.
48. Mutlu A, Gyulkhandanyan AV, Freedman J, Leytin V. Activation of caspases-9, -3 and -8 in human platelets triggered by BH3-only mimetic ABT-737 and calcium ionophore A23187: caspase-8 is activated via bypass of the death receptors. Br J Hematol 2012; 159:565-71.
49. Zamzami N, Marchetti P, Castedo M, et al. Sequential reduction of mitochondrial transmembrane potential and generation of reactive oxygen species in early programmed cell death. J Exp Med 1995;182:367-77.